Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis

THURSDAY, Aug. 28, 2025 (HealthDay News) -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart fail